Country for PR: United States
Contributor: PR Newswire New York
Wednesday, November 02 2022 - 12:04
NCCN Working with Medlive to Advance High-Quality Cancer Care in China and Worldwide
PLYMOUTH MEETING, Pa., Nov. 2, 2022 /PRNewswire-AsiaNet/ --

--United States-based National Comprehensive Cancer Network enters strategic 
cooperation agreement with Chinese medical information website to publish and 
translate evidence-based expert consensus guidelines for cancer care; now 
available at ( 

The National Comprehensive Cancer Network(R) (NCCN ( 
)(R))-an alliance of leading cancer centers ( 
) in the United States-is announcing a new collaboration with Medlive to share 
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(R) ( 
) in China at ( 
). NCCN Guidelines(R) are the recognized standard for clinical direction and 
policy in cancer management and the most thorough and frequently-updated 
clinical practice guidelines available in any area of medicine.

Logo -

The current library of 84 evidence-based, expert consensus practice guidelines 
cover 97% of cancer cases affecting patients-with specific treatment 
recommendations for nearly every type of cancer, plus supportive care and 
prevention-and are updated at least once-a-year. There are also 65 
patient-focused versions of the guidelines for patients and caregivers. All are 
now available at quicker in-country download speeds with a one-step 
registration process, also via ( 
) on computer or the Medlive APP on smartphone. These resources will also be 
translated into Chinese in the future.

"We are committed to making sure providers and patients have access to the most 
up-to-date standards in cancer care around the world," said Robert W. Carlson, 
MD, Chief Executive Officer, NCCN. "At NCCN, we believe that everyone worldwide 
should benefit from the rapidly expanding knowledge on how to treat cancer most 
effectively; and we work tirelessly to make that happen. We are proud to 
collaborate with Medlive on this important project."

Although NCCN is a U.S.-based organization, NCCN resources are accessed and 
utilized throughout the world. Nearly half of the 1.5 million registered users 
viewing NCCN Guidelines at ( 
) or via the Virtual Library of NCCN Guidelines(R) app ( 
) are located outside of the U.S. China is currently the third-highest country 
for clinical practice guideline downloads, with more than 400,000 per year. 
This new in-country platform for guidelines is expected to increase that number 

"We are happy to introduce a new home for NCCN resources in China here on our 
Medlive platform, providing doctors with faster access to NCCN Guidelines," 
said Tian Lixin, President, Medlive. "This collaboration will help oncologists 
in China to reference the widely-recognized NCCN Guidelines, so all patients 
can receive high-quality, effective, and efficient treatment according to the 
latest evidence-based expert consensus standards."

"Both NCCN and Medlive recognize the importance of collaboration and mutual 
learning," said Xin Jiangtao, Vice President, Medlive. "We are pleased to use 
this platform for knowledge sharing between oncology circles in Asia and the 
United States, ultimately improving care for patients everywhere."

The collaboration will focus on providing the full English-language library of 
NCCN Guidelines on Medlive's platform (in addition to their longtime home at ( 
)), with Chinese translations to follow in the near future. The new website 
specifically for NCCN on Medlive was first announced on June 15, 2022 with a 
live conference hosted by Medlive. The full broadcast is available on-demand at ( 

Visit ( 
) to learn more about NCCN's work to improve cancer outcomes around the world. 
Join the conversation online with the hashtag #NCCNGlobal ( 

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network(R) (NCCN ( 
)(R)) is a not-for-profit alliance of leading cancer centers ( 
) devoted to patient care, research, and education. NCCN is dedicated to 
improving and facilitating quality, effective, equitable, and accessible cancer 
care so all patients can live better lives. The NCCN Clinical Practice 
Guidelines in Oncology (NCCN Guidelines ( 
)(R)) provide transparent, evidence-based, expert consensus recommendations for 
cancer treatment, prevention, and supportive services; they are the recognized 
standard for clinical direction and policy in cancer management and the most 
thorough and frequently-updated clinical practice guidelines available in any 
area of medicine. The NCCN Guidelines for Patients ( 
)(R) provide expert cancer treatment information to inform and empower patients 
and caregivers, through support from the NCCN Foundation ( 
)(R). NCCN also advances continuing education ( 
), global initiatives ( 
), policy ( 
), and research collaboration ( 
) and publication( 
) in oncology. Visit ( 
) for more information and follow NCCN on Facebook @NCCNorg ( 
), Instagram @NCCNorg ( 
), and Twitter @NCCN ( 

Media Contact:
Rachel Darwin

SOURCE: National Comprehensive Cancer Network